Ireland
--:--IST
Enrolling by invitation Not applicable

Comparison of Ultrasound-guided Electrolysis Therapy vs. Sham Electrolysis in Patients With Patellar Tendinopathy: A Prospective Randomized Study Including MRI and Shear-wave Ultrasound Elastography Imaging

NCT06939491 · tracked via the Priya Life Science Germany tracker
Sponsor
Gymna Uniphy
Phase
Not applicable
Started
2024-10-29
Last updated
2025-04-30

Condition(s) studied

Patellar Tendinopathy / Jumpers Knee

Investigational drug(s) / intervention(s)

Ultrasound guided electrolysis therapySham Electrolysis

Ultrasound guided electrolysis therapy: Ultrasound-guided galvanic electrolysis (USGET) is a technique most commonly used on chronically affected tissue. A galvanic current flows through an acupuncture needle producing an inflammatory reaction in the tissue. The inflammatory reaction will trigger a host of biological processes in the body. These will ultimately start the generation of new immature collagen fibres. The fibres become mature by means of training stimulus. The technique shows good results on tendons in the chronic phase, and may be used for injuries, such as long-standing muscle injury and treatment of myofascial pain syndrome and trigger points.

Sham Electrolysis: The same intervention as the electrolysis group with the device turned on but the current intensity turned to 0 mA (e.g., no galvanic current).

Study summary

Study Background and Purpose Tendinopathies are common and debilitating musculoskeletal disorders that often lead to chronic pain and reduced mobility. Traditional treatments face challenges due to limited tendon blood supply, leading to poor healing. This study investigates ultrasound-guided galvanic electrolysis therapy (USGET), which uses electric current to promote tendon healing, comparing its efficacy with a placebo.

Objectives The primary goal is to assess pain reduction, while secondary goals evaluate functionality, elasticity, and morphological changes (imaging) in patients with patellar tendinopathy.

Methodology

* Design: Prospective, randomized, double-blind, placebo-controlled study.
* Duration: 24 months (October 2024 - October 2026).
* Groups:
* Intervention Group: Electrolysis therapy with galvanic current, Progressive tendon-loading exercises.
* Control Group: Electrolysis placebo (without current), Progressive tendon-loading exercises.
* Sample Size: 74 subjects.
* Data Collection: Baseline, post-treatment (4 months), and follow-up (7 months).

Evaluation and Data Analysis The study assesses pain via VAS and functionality scores, alongside imaging (MRI, sonography) to measure tendon morphology. Statistical analysis includes hypothesis testing and regression using SPSS software.

Ethics and Publication Ethics approval is from the Bremen Medical Chamber. Results will be published regardless of outcome, following Good Clinical Practice and the Declaration of Helsinki.

Eligibility

Sex
ALL
Min age
18 Years
Max age
59 Years
Healthy volunteers
No
Inclusion Criteria: * Age: 18 - 59 years, * Informed consent (capable of giving consent), * Presentation and diagnosis of patella tendinopathy without other concomitant musculoskeletal diseases or degenerative joint disease. Exclusion Criteria: * Children (\< 18 years), age \> 59 years, * Pregnancy and breastfeeding, * Patients who are unable to give consent, * Musculoskeletal concomitant diseases such as fractures, sprains, dislocations, structural muscle injuries, meniscopathies, cruciate ligament injuries, * Joint diseases (acute, degenerative) such as arthrosis or arthritis, * Acute infections / open wounds in the area of the tendon to be examined * Other relevant damage to the tendon to be examined * Local steroid injections into the tendon before and after the start of the study, * Injections of vascular sclerosing agents before and after the start of the study, * Ingestion of fluoroquinolones, anticoagulants or anti-inflammatory drugs.

Primary outcome measure(s)

  • Visual Analogue Scale (VAS) — Change from baseline to the end of treatment at 10 weeks
    The pain Visual Analogue Scale (VAS) is a subjective, unidimensional measure of pain intensity, used to record patients' pain progression. It is a horizontal line, 100 mm in length, that represent the severity of symptoms from 0 "no symptoms" to 10 "very severe symptoms." The patient marks on the line the point that the patient believes represents his or her perception of his or her current state.
  • Visual Analogue Scale (VAS) — Change from baseline to 7 months follow-up
    The pain Visual Analogue Scale (VAS) is a subjective, unidimensional measure of pain intensity, used to record patients' pain progression. It is a horizontal line, 100 mm in length, that represent the severity of symptoms from 0 "no symptoms" to 10 "very severe symptoms." The patient marks on the line the point that the patient believes represents his or her perception of his or her current state.

Trial sites (1)

FacilityCityRegionStatus
Paracelsus Sportmedizin & Prävention Bremen Bremen Free Hanseatic City of Bremen
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06939491 on ClinicalTrials.gov ↗ ← All trials in Germany